» Articles » PMID: 16828986

Comparative Analysis of Structure, Expression and PSD95-binding Capacity of Lrfn, a Novel Family of Neuronal Transmembrane Proteins

Overview
Journal Gene
Specialty Molecular Biology
Date 2006 Jul 11
PMID 16828986
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Leucine-rich repeat and fibronectin III domain-containing (Lrfn) has five members in mouse and human (Lrfn1, Lrfn2, Lrfn3, Lrfn4, Lrfn5), and homologues in other vertebrates. Lrfn proteins share leucine-rich repeat (LRR)-immunoglobulin-like (Ig)-fibronectin type III (Fn)-transmembrane domain structure, which is also found in LRR-Ig-Fn superfamily proteins. Mouse Lrfn genes were expressed at adult stage predominantly in the brain. In the course of development, expression of Lrfn1, Lrfn3, and Lrfn4 started from immature neural cells, whereas that of Lrfn2 and Lrfn5 was limited to mature ones. Lrfn1-5 commonly encode glycoproteins spanning the plasma membrane, with their N-terminus located on the extracellular side. C-termini of Lrfn1, Lrfn2 and Lrfn4 were bound by PDZ domains of postsynaptic protein PSD95, re-distributing PSD95 to cell periphery where the Lrfn proteins were detected. These results suggest that Lrfn proteins are neuronal components with a role in the developing or mature vertebrate nervous system.

Citing Articles

Dual-specificity protein phosphatase 6 (DUSP6) overexpression reduces amyloid load and improves memory deficits in male 5xFAD mice.

Pan A, Audrain M, Sakakibara E, Joshi R, Zhu X, Wang Q Front Aging Neurosci. 2024; 16:1400447.

PMID: 39006222 PMC: 11239576. DOI: 10.3389/fnagi.2024.1400447.


Cone Synaptic function is modulated by the leucine rich repeat (LRR) adhesion molecule LRFN2.

Hasan N, Gregg R eNeuro. 2024; .

PMID: 38408870 PMC: 10957230. DOI: 10.1523/ENEURO.0120-23.2024.


Retinal transcriptome profiling identifies novel candidate genes associated with visual impairment in a mouse model of multiple sclerosis.

Hong S, Weerasinghe-Mudiyanselage P, Kang S, Moon C, Shin T Anim Cells Syst (Seoul). 2023; 27(1):219-233.

PMID: 37808551 PMC: 10552570. DOI: 10.1080/19768354.2023.2264354.


POU2F1/DNMT3a Pathway Participates in Neuropathic Pain by Hypermethylation-Mediated LRFN4 Downregulation Following Oxaliplatin Treatment.

Gu Y, Wang J, Lu W, Cheng Y, Tao R, Zhang S Neurochem Res. 2023; 48(12):3652-3664.

PMID: 37592110 DOI: 10.1007/s11064-023-04011-w.


LRFN5 and OLFM4 as novel potential biomarkers for major depressive disorder: a pilot study.

Xu K, Zheng P, Zhao S, Wang J, Feng J, Ren Y Transl Psychiatry. 2023; 13(1):188.

PMID: 37280213 PMC: 10244395. DOI: 10.1038/s41398-023-02490-7.